Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq® (Atezolizumab) at the American Society of Clinical Oncology Virtual Annual Meeting
June 04, 2021 09:01 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, June 04, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial
June 01, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, June 01, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 25, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Announces Poster Presentations at the 2021 ASCO Virtual Annual Meeting
May 20, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 05, 2021 16:03 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics
May 03, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON to Report First Quarter 2021 Financial Results and Company Highlights on May 5, 2021
April 28, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, April 28, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting
March 23, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference
March 09, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
Tracon Pharmaceuticals, Inc. Logo
TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors
March 08, 2021 08:05 ET | TRACON Pharmaceuticals, Inc.
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...